VantAI
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
116 E 16th St Fl 12, New York, New York,...Phone Number
+54 3424695740Website
www.vant.aiRevenue
$5.6 MillionIndustry
About VantAI
Proxima is focused on revolutionizing medicine by making protein interactions programmable through its integrated discovery platform, which includes inducers, modulators, and blockers. The company collaborates with industry leaders to advance proximity-based medicines and has recently raised significant funding to enhance AI-driven drug discovery. Proxima's strategic alliances, such as with Halda Therapeutics, aim to develop next-generation therapeutics with substantial market potential. Their mission is to tackle complex scientific challenges at the intersection of artificial intelligence and drug discovery.Explore more
VantAI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to VantAI
Compare insights from companies similar to VantAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VantAI
$5.6M
11-50
Private
-
2019
AG
Alexander GoncearencoSenior Principal and Director Head Of Computational Biology
VantAI Tech Stack
A closer look at the technologies used by VantAI
Top Business Services Companies
Frequently Asked Questions Regarding VantAI
Sign Up For FreeTo access detailed company insights
Proxima is focused on revolutionizing medicine by making protein interactions programmable through its integrated discovery platform, which includes inducers, modulators, and blockers. The company collaborates with industry leaders to advance proximity-based medicines and has recently raised significant funding to enhance AI-driven drug discovery.... Read More
